PATENT CLAIM ANALYSIS

Application Number: 16258115
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "002800"]

Abstract:
A pharmaceutical composition comprising: (a) an isolated peptide, wherein the peptide includes three or four arginine-rich domains (ARDs) from the carboxy-terminal region of hepatitis B virus core protein (HBc) and exhibits an anti-microbial activity; and (b) a pharmaceutically acceptable carrier.

Claim (Index 9):
The composition of  claim 1 , wherein the peptide exhibits an activity against a bacterium and/or fungus.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14766359', '13497622', '11871898', '13497006', '10638125']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.783331005967675
- 35 USC 102 Novelty (BERT): 0.5938897756899318
- Combined Prediction Score: 0.7643868829399008
- Mean Citation Score: 314.476056
- Max Citation Score: 503.10205
- Similarity Product: 460.5891696576954

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test